Please Note: This trial is no longer enrolling new participants
Significance of STK11/LKB1 or Keap1 mutations in Stage III Non-Small Cell Lung Cancer
| Protocol No. | CTO-IUSCC-0726 | Scope | Local |
|---|---|---|---|
| Principal Investigator | Nasser Hanna | Treatment Type | Retrospective |
| Age Group | Phase | NA |
